Abstract:Lung cancer has the highest mortality rate among all cancers worldwide. The 5-year overall survival rate for non-small cell lung cancer (NSCLC) is estimated at around 26%, whereas for small cell lung cancer (SCLC), the survival rate is only approximately 7%. This disease places a significant financial and psychological burden on individuals worldwide. The symbiotic microbiota in the human body has been significantly associated with the occurrence, progression, and prognosis of various diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Studies have demonstrated that respiratory symbiotic microorganisms and their metabolites play a crucial role in modulating immune function and contributing to the pathophysiology of lung cancer through their interactions with the host. In this review, we provide a comprehensive overview of the microbial characteristics associated with lung cancer, with a focus on the respiratory tract microbiota from different locations, including saliva, sputum, bronchoalveolar lavage fluid (BALF), bronchial brush samples, and tissue. We describe the respiratory tract microbiota's biodiversity characteristics by anatomical region, elucidating distinct pathological features, staging, metastasis, host chromosomal mutations, immune therapies, and the differentiated symbiotic microbiota under the influence of environmental factors. Our exploration investigates the intrinsic mechanisms linking the microbiota and its host. Furthermore, we have also provided a comprehensive review of the immune mechanisms by which microbiota are implicated in the development of lung cancer. Dysbiosis of the respiratory microbiota can promote or inhibit tumor progression through various mechanisms, including DNA damage and genomic instability, activation and regulation of the innate and adaptive immune systems, and stimulation of epithelial cells leading to the upregulation of carcinogenesis-related pathways.

Exploring the microbiome: Uncovering the link with lung cancer and implications for diagnosis and treatment

The Function and Molecular Mechanism of Commensal Microbiome in Promoting Malignant Progression of Lung Cancer

Role of Respiratory System Microbiota in Development of Lung Cancer and Clinical Application

Interplay Between the Lung Microbiome and Lung Cancer.

Human Microbiota: a Crucial Gatekeeper in Lung Cancer Initiation, Progression, and Treatment

Microbiology and Lung Cancer: A Comprehensive Review

The Human Microbiome: A Promising Target for Lung Cancer Treatment

Microbiome Dysbiosis in Lung Cancer: from Composition to Therapy

[Progress of Research on the Relationship between Lung Microbiome and Lung Cancer].

Microbes in lung cancer initiation, treatment, and outcome: Boon or bane?

Host-Microbiome Interaction in Lung Cancer

Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies

Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected

The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunity

The implication of microbiome in lungs cancer: mechanisms and strategies of cancer growth, diagnosis and therapy

Lung microbiome in lung cancer: A new horizon in cancer study

The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy

Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment

Exploring the lung microbiome's role in disease

Impact of the Lung Microbiota on Development and Progression of Lung Cancer

Microbes for lung cancer detection: feasibility and limitations